BACKGROUND: Endothelial dysfunction has been described in obesity. This study examines the impact of visceral obesity on nitric oxide-independent relaxation in the human forearm. METHODS AND RESULTS: In ten viscerally obese and ten matched controls forearm blood flow (FBF) was measured by venous occlusion plethysmography during intrabrachial infusion of: (1) sodium nitroprusside; (2) bradykinin, before and after inhibition of vasoactive prostaglandins and nitric oxide; (3) potassium; (4) ouabain (Na(+)/K(+)ATPase inhibitor) alone or (5) in combination with BaCl(2)(K(IR)inhibitor). Baseline FBF and endothelium-independent vasodilatation were similar in the two groups. In obese patients, bradykinin-induced increase of FBF was significantly less than in controls (P<0.01). Irrespective of prostaglandins and nitric oxide inhibition, bradykinin response was lower in the viscerally obese. Intrabrachial potassium determined a significantly blunted response (P<0.05). Ouabain caused a similar, moderate decrease in basal FBF in the two groups; the coinfusion of BaCl(2)caused a more intense decline in FBF which was significantly relevant in obese (-24+/-5%, P<0.01). CONCLUSIONS: In obese patients there is a blunted nitric oxide-independent relaxation determined by a decreased response of inwardly rectifying potassium channels.
BACKGROUND: Endothelial dysfunction has been described in obesity. This study examines the impact of visceral obesity on nitric oxide-independent relaxation in the human forearm. METHODS AND RESULTS: In ten viscerally obese and ten matched controls forearm blood flow (FBF) was measured by venous occlusion plethysmography during intrabrachial infusion of: (1) sodium nitroprusside; (2) bradykinin, before and after inhibition of vasoactive prostaglandins and nitric oxide; (3) potassium; (4) ouabain (Na(+)/K(+)ATPase inhibitor) alone or (5) in combination with BaCl(2)(K(IR)inhibitor). Baseline FBF and endothelium-independent vasodilatation were similar in the two groups. In obesepatients, bradykinin-induced increase of FBF was significantly less than in controls (P<0.01). Irrespective of prostaglandins and nitric oxide inhibition, bradykinin response was lower in the viscerally obese. Intrabrachial potassium determined a significantly blunted response (P<0.05). Ouabain caused a similar, moderate decrease in basal FBF in the two groups; the coinfusion of BaCl(2)caused a more intense decline in FBF which was significantly relevant in obese (-24+/-5%, P<0.01). CONCLUSIONS: In obesepatients there is a blunted nitric oxide-independent relaxation determined by a decreased response of inwardly rectifying potassium channels.
Authors: Ivana Grizelj; Ana Cavka; Jing-Tan Bian; Mary Szczurek; Austin Robinson; Shruti Shinde; Van Nguyen; Carol Braunschweig; Edward Wang; Ines Drenjancevic; Shane A Phillips Journal: Microcirculation Date: 2015-01 Impact factor: 2.628
Authors: Shailendra P Singh; Joseph Schragenheim; Jian Cao; John R Falck; Nader G Abraham; Lars Bellner Journal: Prostaglandins Other Lipid Mediat Date: 2016-07-11 Impact factor: 3.072
Authors: Michelle M Harbin; Hanan Zavala; Justin R Ryder; Julia Steinberger; Alan R Sinaiko; David R Jacobs; Donald R Dengel Journal: Physiol Meas Date: 2018-04-20 Impact factor: 2.833
Authors: Nader G Abraham; Komal Sodhi; Anne M Silvis; Luca Vanella; Gaia Favero; Rita Rezzani; Craig Lee; Darryl C Zeldin; Michal L Schwartzman Journal: Hypertension Date: 2014-09-22 Impact factor: 10.190